The fact that cancer cell proliferation and invasion can be affected by disrupting the interaction between participating factors in Rho signaling pathways provides a rationale for developing pharmacological compounds to prevent malignancies and to establish advanced personalized treatment algorithms with effective therapeutic agents/targets. Here, RHO is linked to cancer.